GenSight will participate to the 2019 Annual Meeting of the American Society for Retina Specialists (ASRS) in Chicago, IL (US), from 26-30 July 2019.
One poster will present GS030, our lead gene therapy product candidate, an innovative optogenetic treatment that started a Phase I/II PIONEER clinical trial in Europe and US with patients affected by Retinitis Pigmentosa (RP).
GS030 – Optogenetics in Retinitis Pigmentosa (RP)
E-poster presentation and Scientific Poster
Title – THE PIONEER STUDY brings Optogenetics to the Clinic: a Phase 1/2 Gene Therapy Program for Non-Syndromic Retinitis Pigmentosa
- Scientific poster will be displayed Saturday through Tuesday
- Q&A session with presence of the poster author: Monday, July 29 – 3:35-4:35 PM CST
- Poster Author: Joseph Martel, MD, Assistant Professor of Ophthalmology Retina and Vitreous Servious, UPMC Eye Center – Eye & Ear Institute, Pittsburg, PA (US)